Platelet-Derived Growth Factor alpha Receptor
Molecular structure and transcriptional regulation of the gene for the platelet derived growth factor alpha receptor in cultured vascular smooth muscle cells
11
Platelet derived growth factor receptor alpha mediates nodal metastases in papillary thyroid cancer by driving the epithelial- mesenchymal transition
17
Olaratumab: a platelet-derived growth factor receptor-α-blocking antibody for the treatment of soft tissue sarcoma
6
Structural analysis of platelet-derived growth factor receptor alpha by protein homology modeling
25
Immunolocalization of platelet‐derived growth factor receptor‐β (PDGFR‐β) and pericytes in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL)
14
Inhibition of the platelet derived growth factor receptor beta (PDGFRB) using gene silencing, crenolanib besylate, or imatinib mesylate hampers the malignant phenotype of mesothelioma cell lines
17
Olaratumab in soft tissue sarcoma - Current status and future perspectives.
7
Type H blood vessels in bone modeling and remodeling
11
Chrysotile asbestos upregulates gene expression and production of alpha receptors for platelet derived growth factor (PDGF AA) on rat lung fibroblasts
7
Regional expression of the platelet derived growth factor and its receptors in a primate graft model of vessel wall assembly
12
Inhibition of the platelet-derived growth factor receptor beta (PDGFRB) using gene silencing, crenolanib besylate, or imatinib mesylate hampers the malignant phenotype of mesothelioma cell lines
15
Function and regulation of Platelet-Derived Growth Factor Receptor Alpha during development
224
The Bovine Papillomavirus E5 Protein Requires a Juxtamembrane Negative Charge for Activation of the Platelet-Derived Growth Factor β Receptor and Transformation of C127 Cells
9
Evaluation of effectiveness of concentrated growth factor on osseointegration
6
Effect of tyrosine kinase inhibitors, imatinib and nilotinib, in murine lipopolysaccharide induced acute lung injury during neutropenia recovery
11
Inhibition of Bone Marrow-Derived Mesenchymal Stem Cells Homing Towards Triple-Negative Breast Cancer Microenvironment Using an Anti-PDGFRβ Aptamer
13
Growth factor levels in leukocyte-poor platelet-rich plasma and correlations with donor age, gender, and platelets in the Japanese population
8
Rationale for targeting VEGF, FGF, and PDGF for the treatment of NSCLC
16
B cell depletion therapy in patients with diffuse systemic sclerosis associates with a significant decrease in PDGFR expression and activation in spindle like cells in the skin
9
Neovascular age-related macular degeneration: intraocular inflammatory cytokines in the poor responder to ranibizumab treatment
9